- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
US Moves to End Its Suit Against Michigan Blue Cross Blue Shield in View of New State Law
WASHINGTON — The Justice Department is moving to dismiss its lawsuit against Blue Cross Blue Shield of Michigan now that a new state law prohibits the anti-competitive practice at issue in the case.
In 2010, the Justice Department and Michigan sued to stop Michigan Blue Cross Blue Shield from entering business arrangements with health care providers which, according to the lawsuit, essentially guaranteed that no competing health care plan could obtain a better rate. Michigan and Blue Cross joined the motion to dismiss.
According to the lawsuit in federal court in Detroit, contract provisions called “most favored nation clauses” raised hospital prices charged to other insurers, prevented insurers from entering local markets and discouraged discounts.
Read the full story: http://wapo.st/16U0w68
Source: WashingtonPost.com
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
